WATCH: Timelapse video of progress on North East's new eye hospital
The new Sunderland Eye Infirmary is set to open in summer 2026 and will serve patients from across the North East and North Cumbria.
A time-lapse video of the build has been released to mark the one-year milestone, showing progress since construction began 18 months ago.
Construction began in December 2023 and the internal fit-out is now well underway.
Dr Ajay Kotagiri, clinical director of ophthalmology services at South Tyneside and Sunderland NHS Foundation Trust, said: "It was brilliant to visit the new hospital site and amazing to see the actual space we will be working in from next summer.
"The clinical areas are so spacious and well designed and we can't wait to be able to see and treat patients in this fantastic new facility."
The new hospital will house all current clinical services from the Queen Alexandra Road site, including the Cataract Treatment Centre, which plays a key role in reducing waiting lists across the region.
Ophthalmology remains one of the busiest services in the NHS, with many people experiencing sight problems during their lives.
Alongside the construction, the Trust's STS Charity has launched the Vision Appeal, aiming to raise £1 million to fund advanced technology and equipment beyond what is included in the hospital build.
Dr Kotagiri said: "Our Vision Appeal is a great way for patients and local people to get involved with the new Eye Hospital and be part of something fantastic.
"We want to stay at the forefront of eye research and innovation in Sunderland and the STS Charity's support will help us do that.
"It will help us to fund equipment and technology, over and above what we already have."
The new hospital forms part of the Riverside Sunderland development and is being built by Kier in partnership with Sunderland City Council.
READ MORE:
Rare breed of horse cherished by the late Queen joins Bishop Auckland theatre show
Town to step out in style for ball in memory of 'much-loved' Grace and Wendy
Plans to transform Grade II-listed church into housing, offices, and gym approved
Councillor Kevin Johnston, cabinet member for business, housing and regeneration, said: "It's fantastic to see work progressing apace on the new Eye Hospital at Riverside Sunderland.
"Once complete, this world-class facility will be one of the few standalone specialist eye hospitals anywhere in the UK and the region's only dedicated specialist centre for ophthalmology care."
The hospital will also include wellbeing rooms, a café overlooking the River Wear, and a children's area with dedicated waiting and treatment rooms.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
16 minutes ago
- CNN
‘It's heartless, it's careless, and it's deeply damaging' says former NIH director on cuts to medical research
Dr. Francis Collins, former director of the National Institutes of Health, speaks to Christiane Amanpour about his decision to leave the agency and what he says is the Trump administration's crackdown on science.
Yahoo
18 minutes ago
- Yahoo
This Handwriting Change May Be An Early Sign Of Parkinson's
Parkinson's disease, the condition Ozzy Osborne was diagnosed with roughly five years before his death, affects about 153,000 people in the UK at the moment. It is a progressive neurological disease. While there is no single, outright cure for it yet, the NHS says therapies like medication and physiotherapy can minimise its symptoms for many. But sadly, the condition is often misdiagnosed, even though early diagnosis can be very beneficial. That's why organisations like Parkinson's UK champion better, earlier diagnoses, and hope one day for a single test that can accurately spot the disease as soon as possible. In the meantime, however, they've shared early signs of the condition; one of which involves changes to your handwriting. How is handwriting linked to Parkinson's? Parkinson's UK says that noticing smaller handwriting over time is one potential early sign. This is called micrographia, and could affect as many as 50-60% of people living with Parkinson's, though the numbers are not settled. 'You may notice the way you write words on a page has changed, such as letter sizes are smaller and the words are crowded together,' the charity shared. A 2022 paper suggested that the handwriting change may precede other motor symptoms of Parkinson's, like tremors. Parkinson's is not the only cause of handwriting changes – it's been linked to other neurological changes, while Parkinson's UK says 'writing can change as you get older, if you have stiff hands or fingers or poor vision' – but it may be worth seeing your doctor about it, especially if it comes with other symptoms. What are the other early symptoms of Parkinson's? According to Parkinson's UK, having a single early symptom doesn't mean you've got the disorder. But 'if you have more than one sign, you should consider making an appointment to talk to your doctor,' they wrote. Aside from micographia, the other possible symptoms they listed were: Tremors. Shaking in your finger, thumb, hand, or chin while at rest is a common early symptom. Loss of smell, especially for strongly-scented foods like bananas, liquorice, and gherkins. Moving a lot in your sleep, especially if you start acting out your dreams or thrashing around a lot. Trouble with movement or walking. You might find your arms don't swing as much as they used to when you walk, that your limbs or stiff, that your shoulders of hips feel tight, or that your feet feel 'stuck to the floor.' Constipation. This can be normal, but it can persist with Parkinson's. Developing a soft, low voice that others might describe as hoarse or breathy and which might sound quieter than usual. 'Facial masking,′ or a sad or angry expression on your face that happens regardless of your mood. Dizziness or fainting, for instance, when getting up out of a chair – this can be linked to low blood pressure, which is associated with Parkinson's. Stooping or hunching over, especially if this is new for you. Related... 'Super Smeller' Inspires Test To Spot Parkinson's 7 Years Before Diagnosis Gut Health Discovery Could Help Future Parkinson's Diagnoses Parkinson's Cases Are Set To Double By 2050. Here Are 5 Early Signs To Watch For
Yahoo
30 minutes ago
- Yahoo
UnitedHealthcare Pressure Builds: Trouble Ahead for UNH's Q2 Earnings?
UnitedHealth Group Incorporated UNH is set to release its second-quarter 2025 results on July 29, 2025, before market open. As a bellwether in the healthcare sector, UNH's performance offers critical insight into the broader health insurance landscape, an industry currently grappling with surging medical costs and mounting regulatory scrutiny. Plunging profits from its UnitedHealthcare unit are expected to have affected UNH's second-quarter results. Recent challenges, including the withdrawal of the 2025 earnings outlook, a surprise CEO transition, and damaging headlines about federal investigations, have significantly eroded investor confidence. On Thursday, the company confirmed that the Department of Justice is probing aspects of its Medicare business. UNH stated it had 'proactively reached out to the Department of Justice' after reviewing media reports and is now 'complying with formal criminal and civil requests.' Following UNH's lead, peers like Centene and Humana Inc. HUM withdrew their 2025 profit outlook, while Molina Healthcare, Inc. MOH slashed its guidance. The stock performance across the managed care industry reflects these concerns: year to date, UNH shares have plunged 45%, matching Molina Healthcare's decline, while Humana is down 9.7%. The broader industry has tumbled 34.3% over the same period, sharply underperforming the S&P 500's 7.6% gain. YTD Price Performance – UNH, HUM, MOH, Industry & S&P 500 Image Source: Zacks Investment Research Despite the sharp sell-off, UnitedHealth still trades at 11.98X forward 12-month earnings, slightly above the industry average of 11.58X. However, this is well below the company's five-year median P/E of 19.20X, reflecting the market's growing concerns around operational stability and regulatory risk. Image Source: Zacks Investment Research In comparison, Humana and Molina Healthcare are currently trading at 15.76X and 6.48X, respectively. Now let's focus on the UnitedHealthcare, UNH's biggest segment by revenue generation. Spotlight on UnitedHealthcare Segment Through this segment, UNH offers healthcare benefits worldwide. While it has significant exposure to the Medicare and Medicaid markets, it also serves individuals and employers. The defensive properties of the sector enabled UnitedHealth to maintain its momentum, which is now impacted by rising medical costs in Medicare Advantage and a surge in high-acuity patient volumes. In the last reported quarter, the segment's revenues jumped 12.3% year over year to $84.6 billion, whereas the operating income improved 18.9% to $5.2 billion. Considering the unit's products, premiums increased 12.8% year over year to $81.5 billion in the first quarter, while service revenues grew 1.9% to $2.6 billion. Total revenues from the Employer & Individual Domestic, Medicare & Retirement and Community & State businesses increased 6.9%, 17.5% and 12.5% year over year, respectively. But, from global operations, UNH reported revenues of $782 million, down 49% year over year. Q2 Segment Expectations: Revenues to Rise, Profits to Fall The Zacks Consensus Estimate for UnitedHealthcare's revenues indicates a 14.7% year-over-year increase from the year-ago level of $73.9 billion, whereas our model estimate suggests a 14.1% rise. The consensus mark for second-quarter operating income signals a more than 30% year-over-year decline from $4 billion a year ago. With growing elective procedures, medical costs are expected to have remained elevated in the second quarter. This is expected to have resulted in UNH having a lower portion of premiums remaining after settling payments. As such, the consensus mark for the second-quarter 2025 medical care ratio is pegged at 88.6%, indicating an increase from the year-ago level of 85.1%, while our estimate of 87% suggests a lower jump. The consensus estimate for Employer & Individual Domestic revenues indicates more than 6% year-over-year growth to nearly $19.8 billion. The consensus mark for UnitedHealthcare's Community & State revenues suggests an 18.8% increase from the year-ago period's $19.7 billion, whereas our model predicts a 19% gain. The consensus estimate for Medicare & Retirement business' revenues suggests 18.2% year-over-year growth from $34.9 billion a year ago, while our estimate indicates a 16.3% improvement. The Zacks Consensus Estimate for UnitedHealthcare's total number of people served in the commercial domestic business indicates a 1.5% increase from the year-ago level of 29,570 thousand, while our estimate implies a 1.2% rise. The consensus mark for total UnitedHealthcare medical membership calls for 0.7% year-over-year growth in the second quarter. Final Thoughts Despite a projected 12.8% year-over-year increase in total revenues to $111.55 billion, the UnitedHealthcare unit is anticipated to have positioned the company for a significant year-over-year decline in profits. The Zacks Consensus Estimate for second-quarter earnings is pegged at $4.84 per share, representing a steep 28.8% drop from $6.80 a year ago. UnitedHealth Group Incorporated Price, Consensus and EPS Surprise UnitedHealth Group Incorporated price-consensus-eps-surprise-chart | UnitedHealth Group Incorporated Quote Elevated costs and expenses are expected to have influenced UNH's second-quarter profit margins, creating uncertainty about an earnings beat. Our estimate for total medical costs indicates a nearly 15% year-over-year increase, while we expect operating expenses to have increased by almost 14%. Further, we expect the cost of products sold to have jumped more than 10% year over year in the second quarter. Also, our proven model does not conclusively predict an earnings beat for UnitedHealth. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is not the case here. UnitedHealth has an Earnings ESP of -9.55% and currently carries a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. You can see the complete list of today's Zacks #1 Rank stocks here. Ongoing operational and regulatory headwinds have eroded UnitedHealth's investment appeal. With limited upside and heightened downside risk ahead of second-quarter 2025 results, the Sell rating reflects a cautious stance and urges investors to consider exiting their positions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report Humana Inc. (HUM) : Free Stock Analysis Report Molina Healthcare, Inc (MOH) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
